Insider · CIK 0001926230
James Sherblom
Files at CMRA (Comera Life Sciences Holdings, Inc.). First filing -, latest -.
In brief
James Sherblom files SEC Form 4 as director at CMRA (Comera Life Sciences Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James Sherblom has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | CMRA Comera Life Sciences Holdings, Inc. | AGrant or award Stock Option (Right to Purchase)derivative | +103,643 | $0.00 | $0 | 103,643 | Nov 14, 2023 |
Questions about James Sherblom
Answered from the filings on this page, as of the latest one.
Is James Sherblom buying or selling?
James Sherblom has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James Sherblom's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Sherblom has 0.
Where does James Sherblom file Form 4?
James Sherblom has filed Form 4 at CMRA (Comera Life Sciences Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.